Indian Journal of Pharmacy Practice logo
Article

A Case Report on Stavudine Induced Lipodystrophy

1, 1, 1

  1. 1Department of Pharmacy Practice, Annamacharya College of Pharmacy, Rajampeta, Andhra Pradesh, INDIA.

CORRESPONDENCE

Lakshmi Narasimha Gunturu

Department of Pharmacy Practice, Annamacharya College of Pharmacy, Rajampeta, Andhra Pradesh, INDIA.

gunturunarasimha007@gmail.com

Volume 14, Issue 3 · pp. 222-223 · 2021 · DOI: 10.5530/ijopp.14.3.44

ABSTRACT

Drug induced adverse drug reactions are more common in long term therapy particularly in immune compromised patients. Some of the drugs causes Redistribution of body fat (Lipodystrophy) in Human Immunodeficiency Virus (HIV) infected patients and loss of body fat (Lipoatrophy). Stavudine is the one of the first line regimens drugs used for HIV infection belongs to the category of Nucleoside reverse transcriptase enzyme inhibitor (NRTIs). In the present case, we have reported the stavudine induced severe Lipodystrophy (Lipoma). A patient visited the hospital with the symptoms of lump on back of neck as, she received Stavudine fixed dose combination (SLN) as a drug for her diagnosis of HIV for past seven years. After clear examination Lipodystrophy (Lipoma) was confirmed and suspected with the cause due to stavudine fixed dose regimen. The drug was stopped and the patient was opted to surgery for permanent cure. The patient was recovered from her condition and other antiretroviral drugs were recommended for her treatment.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Gunturu, L. N., Pamayyagari, K., & Dornadula, G. (2021). A Case Report on Stavudine Induced Lipodystrophy. Indian Journal of Pharmacy Practice, 14(3), 222-223. https://doi.org/10.5530/ijopp.14.3.44

    Copyright and licence

    © 2021 Author(s)

    This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. CC BY 4.0